Product Overview
Emjard mxr tab 12.5/1000mg 14s is a medication formulated by HOECHST PAK LTD to help manage diabetes. It contains the active ingredients Empagliflozin and Linagliptin, which work together to regulate blood sugar levels in the body.

Key Benefits
- Helps lower blood sugar levels in individuals with diabetes
- Supports weight loss by promoting the excretion of glucose through urine
- Reduces the risk of cardiovascular events in diabetic patients
- Enhances insulin sensitivity and glucose utilization in the body

How It Works
Empagliflozin works by inhibiting the reabsorption of glucose in the kidneys, leading to increased glucose excretion in the urine. Linagliptin, on the other hand, helps stimulate the release of insulin and inhibit the production of glucagon, a hormone that raises blood sugar levels. Together, these two ingredients help maintain optimal blood sugar levels in diabetic patients.

Directions for Use
1. Take Emjard mxr tab 12.5/1000mg as prescribed by your healthcare provider.
2. Swallow the tablet whole with a glass of water.
3. It is usually taken once daily with or without food.
4. Monitor your blood sugar levels regularly as directed by your doctor.

Precautions
- Inform your doctor about any allergies or medical conditions before starting this medication.
- Avoid alcohol consumption while taking Emjard mxr tab 12.5/1000mg.
- Be cautious while driving or operating machinery as this medication may cause dizziness.

Storage Instructions
Store Emjard mxr tab 12.5/1000mg in a cool, dry place away from direct sunlight and moisture. Keep it out of reach of children and pets.

Manufacturer Information
HOECHST PAK LTD is the manufacturer of Emjard mxr tab 12.5/1000mg 14s. They are committed to providing high-quality medications to improve the health and well-being of individuals worldwide.